Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 17 submissions in the queue.
posted by chromas on Wednesday January 23 2019, @10:24AM   Printer-friendly
from the stop-being-poor dept.

U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds

The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.

A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.

The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by JoeMerchant on Wednesday January 23 2019, @12:52PM

    by JoeMerchant (3937) on Wednesday January 23 2019, @12:52PM (#790583)

    If it's legal for loan sharks, why not for Pharmaceutical manufacturers?

    --
    🌻🌻 [google.com]
    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2